Development of a fully paper-based device for quantitative detection of digoxin at the point of care
We are the first to integrate H<sub>2</sub>O<sub>2</sub> degradation and gold nanorod (GNR) etching on paper with the lateral-flow immunoassay (LFA) in a 3D-printed device to achieve semi-quantitative results for therapeutic drug monitoring of digoxin by correlating different color outputs to different digoxin concentrations.
Authors
- Daniel T. Kamei (ORCID: https://orcid.org/0000-0001-8864-1846)
- Jiakun Lu (ORCID: https://orcid.org/0009-0009-3486-8880)
- Kyle Chen (ORCID: https://orcid.org/0000-0002-3934-2759)
- Jasmine Thanh Trinh
- Audrey T. Sogata (ORCID: https://orcid.org/0009-0007-1694-6190)
- Rika Nicole L Canlas
Institutions
- University of California, Los Angeles (US)
Publication Details
- Journal
- The Analyst
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1039/d5an00800j
- Primary Topic
- Analytical Methods in Pharmaceuticals
- Type
- article
- Field-Weighted Citation Impact
- 0.00